Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | President, EMEA | February 26, 2021 | March 02, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date February 26, 2021 · Filed March 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,619 |
Reported balance
After 2021-02-26 transaction · row 1
1 source rowRow 1 · 2021-02-26 · Exercise / conversion · Acquired 315 · Balance 4,619 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-02-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-02-26 · Exercise / conversion · Disposed 315 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2: Earned RSUs vested on February 26, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
F2: Earned RSUs vested on February 26, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2021 Filed Mar 2, 2021 23:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002182 · form4.xml · derivative · entry 2 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Earned RSUs vested on February 26, 2021. F2 · derivative.expiration_date: Earned RSUs vested on February 26, 2021. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002182 · form4.xml · nonDerivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:53 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 17,749 | $0.00 Strike: $163.79 | $0.00 |
DisclosureSEC source: 0001062993-21-002089 · form4.xml · derivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,749 Underlying: Common Stock · 17,749 shares Expires 2031-02-25 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 22:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-001856 · form4.xml · derivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315 Underlying: Common Stock · 315 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 315 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2021. F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2021. F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 315 RSUs. F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 315 RSUs. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 20:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-20-004388 · form4.xml · derivative · entry 2 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,108 Underlying: Common Stock · 1,554 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: The RSUs vest as follows: 1,554 vested on each of September 4, 2019 and September 4, 2020; and of the remaining 3,108 RSUs, 1,554 are scheduled to vest on each of September 4, 2021 and September 4, 2022. F2 · derivative.expiration_date: The RSUs vest as follows: 1,554 vested on each of September 4, 2019 and September 4, 2020; and of the remaining 3,108 RSUs, 1,554 are scheduled to vest on each of September 4, 2021 and September 4, 2022. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 20:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-20-004388 · form4.xml · nonDerivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:22 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 1,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000057 · edgar.xml · derivative · entry 2 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,640 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Earned RSUs vested on February 26, 2020. F2 · derivative.expiration_date: Earned RSUs vested on February 26, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:22 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000057 · edgar.xml · nonDerivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:32 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 23,296 | $0.00 Strike: $157.54 | $0.00 |
DisclosureSEC source: 0000911916-20-000033 · edgar.xml · derivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,296 Underlying: Common Stock · 23,296 shares Expires 2030-02-21 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 21, 2021. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 23:00 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000021 · edgar.xml · derivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,640 Underlying: Common Stock · 1,640 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,640 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2020. F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2020. F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,640 RSUs. F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 13, 2020, based on actual performance for 2019, the reporting person earned 1,640 RSUs. Read SEC document |
| September 09, 2019 Filed Sep 10, 2019 20:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 84 | $140.42 | $11,795.28 |
DisclosureSEC source: 0000911916-19-000166 · edgar.xml · nonDerivative · entry 2 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,110 F1 · shares: Securities sold to cover taxes associated with the vesting of restricted stock units on September 4, 2019, which vesting was previously reported by the reporting person. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 20:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 360 | $139.25 | $50,130.00 |
DisclosureSEC source: 0000911916-19-000166 · edgar.xml · nonDerivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,194 F1 · shares: Securities sold to cover taxes associated with the vesting of restricted stock units on September 4, 2019, which vesting was previously reported by the reporting person. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:31 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000164 · edgar.xml · derivative · entry 2 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,662 Underlying: Common Stock · 1,554 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: The RSUs vest as follows: 1,554 vested on September 4, 2019; and of the remaining 4,662 RSUs, 1,554 are scheduled to vest on each of September 4, 2020, September 4, 2021 and September 4, 2022. F2 · derivative.expiration_date: The RSUs vest as follows: 1,554 vested on September 4, 2019; and of the remaining 4,662 RSUs, 1,554 are scheduled to vest on each of September 4, 2020, September 4, 2021 and September 4, 2022. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:31 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000164 · edgar.xml · nonDerivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 24,375 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000062 · edgar.xml · derivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,375 Underlying: Common Stock · 24,375 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 20:19 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 6,216 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000166 · edgar.xml · derivative · entry 2 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,216 Underlying: Common Stock · 6,216 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on September 4, 2019. F1 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on September 4, 2019. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 20:19 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 15,912 | $0.00 Strike: $123.02 | $0.00 |
DisclosureSEC source: 0000911916-18-000166 · edgar.xml · derivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,912 Underlying: Common Stock · 15,912 shares Expires 2028-09-04 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on September 4, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.